GemVax&KAEL Co.,Ltd. (KOSDAQ: 082270)
South Korea
· Delayed Price · Currency is KRW
18,850
+670 (3.69%)
Jan 21, 2025, 3:00 PM KST
GemVax&KAEL Co.,Ltd. Revenue
GemVax&KAEL Co.,Ltd. had revenue of 12.74B KRW in the quarter ending September 30, 2024, a decrease of -6.23%. This brings the company's revenue in the last twelve months to 62.73B, down -8.77% year-over-year. In the year 2023, GemVax&KAEL Co.,Ltd. had annual revenue of 72.21B, down -4.74%.
Revenue (ttm)
62.73B
Revenue Growth
-8.77%
P/S Ratio
11.88
Revenue / Employee
337.27M
Employees
186
Market Cap
747.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 72.21B | -3.60B | -4.74% |
Dec 31, 2022 | 75.80B | 15.43B | 25.56% |
Dec 31, 2021 | 60.37B | -5.29B | -8.06% |
Dec 31, 2020 | 65.66B | 23.00B | 53.91% |
Dec 31, 2019 | 42.66B | -4.58B | -9.69% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |